NCT05950958 Prevention of Delirium in ICU Using Multimodal Interventions
| NCT ID | NCT05950958 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Intensive Care Unit Delirium |
| Study Type | INTERVENTIONAL |
| Enrollment | 196 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 196 participants in total. It began in 2022-08-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was designed to evaluate the impact of non-pharmacological multimodal interventions including ongoing orientation, sensory correction, setting of familiar circumstance and promotion of sleep enviromnet for prevention of delirium in intensive care unit.
Eligibility Criteria
Inclusion Criteria: * Adult patients over 50 years who are expected to spend more than 24 hours in the intensive care unit Exclusion Criteria: * Patients who developed delirium before entering the intensive care unit * Patients with cognitive impairment * Patients who have hearing or vision deficits, or have difficulty in communication * Patients who are expected to die within 24 hours or do not want life-sustaining treatment
Contact & Investigator
Ho Geol Ryu, MD, PhD
STUDY CHAIR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT05950958 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Intensive Care Unit Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05950958 currently recruiting?
Yes, NCT05950958 is actively recruiting participants. Contact the research team at erange@snu.ac.kr for enrollment information.
Where is the NCT05950958 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05950958 clinical trial?
NCT05950958 is sponsored by Seoul National University Hospital. The principal investigator is Ho Geol Ryu, MD, PhD at Seoul National University Hospital. The trial plans to enroll 196 participants.